Close Menu
    Facebook LinkedIn YouTube WhatsApp X (Twitter) Pinterest
    Trending
    • Supermassive black holes may create millions of new planets
    • Cheque in: 3 startups ended May by raising $15.5 million
    • Universal Audio Volt 876 USB Audio Interface Review: Pro-Level Polish
    • New York City-based Mecka AI, which trains robots with human data sourced from body sensors and iPhones, raised $60M, including a $25M Series A (Ben Weiss/Fortune)
    • Is Instagram Down? What to Know
    • It’s the Lessons We Learned Along the Way. Or, Is It?
    • The forever chemicals impacting your health
    • WiseTech CEO threatened amid job cuts; founder Richard White calls in police
    Facebook LinkedIn WhatsApp
    Times FeaturedTimes Featured
    Monday, June 1
    • Home
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    • More
      • AI
      • Robotics
      • Industries
      • Global
    Times FeaturedTimes Featured
    Home»Technology»Supercharging Immune Cells May Help Control HIV Long-Term
    Technology

    Supercharging Immune Cells May Help Control HIV Long-Term

    Editor Times FeaturedBy Editor Times FeaturedMay 19, 2026No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email WhatsApp Copy Link


    A Miracle most cancers remedy that entails engineering a patient’s own immune cells is being repurposed for HIV, and early outcomes from two people trace at its promise for long-term management of the virus.

    As a part of a medical trial, scientists took individuals’s personal immune cells and reprogrammed them in a lab to acknowledge and assault HIV within the physique. After a single infusion of the modified cells, two people with HIV now have undetectable ranges of the virus—one for almost two years and the opposite for nearly a yr. Each have been capable of go off HIV medicines fully.

    The 2 individuals are a part of a small research to check the remedy’s security and feasibility. The preliminary findings had been introduced final week on the of American Society of Gene and Cell Remedy annual assembly in Boston.

    “These are early days. If we will present the proof-of-concept that this strategy is each protected and efficient, then there are many methods wherein it may be optimized, to make it extra inexpensive and scalable,” says Steven Deeks, a professor of medication and HIV skilled on the College of California, San Francisco, who led the trial.

    The method, often called CAR-T cell remedy, has been utilized in tens of thousands of patients with tough-to-treat cancers. Half a dozen or so medication have been accredited that depend on the method. The remedy primarily supercharges an individual’s immune system to straight assault and get rid of most cancers cells. Just lately, it’s additionally been used efficiently to deal with severe autoimmune diseases.

    “That is fairly thrilling,” says Andrea Gramatica, vp of analysis at amfAR, the Basis for AIDS Analysis, who was not concerned within the trial. “The explanation this research issues and is especially vital is as a result of it provides the HIV area an actual, medical clue that educating the immune system to manage the virus with out antiretroviral remedy is achievable.”

    Scientists have been pursuing a treatment for HIV for the reason that virus was first recognized within the early Nineteen Eighties. Antiretroviral remedy prevents the development to AIDS by suppressing the virus to undetectable ranges, however individuals should take medicine for the remainder of their lives. It has remodeled HIV right into a continual situation that enables individuals to have a near-normal life expectancy. But not everybody who’s HIV constructive is conscious of their standing, and in some rural and low-income elements of the world these medicines are nonetheless not broadly accessible or inexpensive.

    Up till now, there are under a dozen documented cases of sustained remission from HIV—often called a “purposeful treatment” as a result of the virus continues to be current within the physique however is suppressed to ranges which can be undetectable by the immune system and HIV medicine is not wanted.

    Every of these people developed most cancers and underwent stem cell transplantations as a part of their remedy. In all however one of those cases, docs used stem cells from donors with a uncommon genetic mutation known as CCR5 that naturally prevents HIV from getting into and infecting wholesome cells. Timothy Ray Brown, often called the “Berlin affected person,” was the primary recognized particular person to be cured of HIV on this approach in 2008.

    The examples of sustained remission “have taught us that the immune system can, below the precise circumstances, clear HIV,” says Boro Dropulić, govt director of the Maryland nonprofit Caring Cross, who developed the CAR-T remedy for HIV.

    However stem cell transplants aren’t scalable, he says. They’re intensive procedures that carry severe dangers equivalent to graft-versus-host illness, when the transplanted cells acknowledge the recipient’s cells as international and assault them.

    “What we’re making an attempt to do is to engineer that final result intentionally with out requiring most cancers, with out requiring a particular donor,” Dropulić says. His group is engaged on making superior therapies like CAR-T extra accessible and inexpensive.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Editor Times Featured
    • Website

    Related Posts

    Universal Audio Volt 876 USB Audio Interface Review: Pro-Level Polish

    June 1, 2026

    Best Sleep Trackers of 2026: Oura, Whoop, and Eight Sleep

    June 1, 2026

    The Painful Truth About Long Covid

    June 1, 2026

    HP Omnibook 3 Review: Redefining the Budget Laptop

    June 1, 2026

    The Vatican’s Man Inside Anthropic

    June 1, 2026

    Everyone Has Their Targets Set on the MacBook Neo

    June 1, 2026
    Leave A Reply Cancel Reply

    Editors Picks

    Supermassive black holes may create millions of new planets

    June 1, 2026

    Cheque in: 3 startups ended May by raising $15.5 million

    June 1, 2026

    Universal Audio Volt 876 USB Audio Interface Review: Pro-Level Polish

    June 1, 2026

    New York City-based Mecka AI, which trains robots with human data sourced from body sensors and iPhones, raised $60M, including a $25M Series A (Ben Weiss/Fortune)

    June 1, 2026
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    About Us
    About Us

    Welcome to Times Featured, an AI-driven entrepreneurship growth engine that is transforming the future of work, bridging the digital divide and encouraging younger community inclusion in the 4th Industrial Revolution, and nurturing new market leaders.

    Empowering the growth of profiles, leaders, entrepreneurs businesses, and startups on international landscape.

    Asia-Middle East-Europe-North America-Australia-Africa

    Facebook LinkedIn WhatsApp
    Featured Picks

    Tech Billionaires Already Captured the White House. They Still Want to Be Kings

    September 27, 2025

    Today’s NYT Connections: Sports Edition Hints, Answers for Feb. 21, #151

    February 20, 2025

    Amazon blocks 1,800 job applications from suspected North Korean agents

    December 23, 2025
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    Copyright © 2024 Timesfeatured.com IP Limited. All Rights.
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us

    Type above and press Enter to search. Press Esc to cancel.